Your browser doesn't support javascript.
loading
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.
Mahalingam, Devalingam; Hanni, Salih; Serritella, Anthony V; Fountzilas, Christos; Michalek, Joel; Hernandez, Brian; Sarantopoulos, John; Datta, Paromitta; Romero, Ofelia; Pillai, Sureshkumar Mulampurath Achutan; Kuhn, John; Pollak, Michael; Thompson, Ian M.
Afiliación
  • Mahalingam D; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Hanni S; Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
  • Serritella AV; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Fountzilas C; Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
  • Michalek J; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Hernandez B; Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Sarantopoulos J; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Datta P; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Romero O; Institute for Drug Development, Mays Cancer Center at University of Texas Health, San Antonio, TX 78229, USA.
  • Pillai SMA; Audie Murphy VA Hospital, San Antonio, TX 78229, USA.
  • Kuhn J; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Pollak M; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
  • Thompson IM; Division of Hematology and Oncology, University of Texas Health Science Center, San Antonio, TX 77030, USA.
Oncotarget ; 14: 622-636, 2023 06 19.
Article en En | MEDLINE | ID: mdl-37335291

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Síndrome Metabólico / Insulinas / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Humans / Male Idioma: En Revista: Oncotarget Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Síndrome Metabólico / Insulinas / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Humans / Male Idioma: En Revista: Oncotarget Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos